Cyril Berthet

Cyril Berthet has extensive experience in the pharmaceutical industry, currently serving as Chief Operating Officer at Oncodesign Services. With a background in molecular genetics and entrepreneurship, Cyril has held various leadership roles including Director of Pharmaco-Imaging and Molecular Radiotherapy Department at Oncodesign, as well as Director of Operations at Pharm'image. Cyril's expertise lies in drug discovery programs and medical imaging technologies for evaluating biomarkers in cancer research.